O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2021ACC: 0001209191-21-000935
Officer· Chief Medical Officer
Since Jun 2018
+338.00
Net shares
Net buyer
$2.8K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
338.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+169.00
Price / share
$16.32
Trade value
$2.76K
% of position
5.6%
12/31/2020
3K→3.17K
Total
Net shares
+169.00
Net value
$2.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2020 | A · Award | +169.00 | $16.32 | $2.76K | 5.6% | 3K | 3.17K |
| Total | +169.00 | $2.76K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
169.00 shares
Shares
+169.00
Strike price
19.20
Held after
169.00
Exercisable
—
12/31/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock169.00 shares | 12/31/2020 | A · Award | +169.00 | 19.20 | — | 169.00 |